Halcinonide topical Alternatives Compared
| Halcinonide topical | Triamcinolone topical | Dupixent |
|
|---|
| Halcinonide topical | Triamcinolone topical | Dupixent (dupilumab) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Eczema, Psoriasis, Atopic Dermatitis, Dermatitis. Halcinonide topical may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Atopic Dermatitis, Dermatitis, Aphthous Ulcer, Lichen Planus, Allergies, Stomatitis, Psoriasis, Eczema. Triamcinolone topical may also be used for purposes not listed in this medication guide. View more |
Prescription only
Dupixent injection is usually given every 1 to 4 weeks to treat asthma, eczema, chronic rhinosinusitis, COPD, eosinophilic esophagitis, or prurigo nodularis. Injection site reactions and eye problems... View more |
Related suggestions |
|||||||||||||||||||||||
| More about Halcinonide topical | More about Triamcinolone topical | More about Dupixent (dupilumab) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Halcinonide topical has an average rating of 9.3 out of 10 from a total of 4 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Triamcinolone topical has an average rating of 7.7 out of 10 from a total of 105 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 20% reported a negative effect. |
Dupixent has an average rating of 7.1 out of 10 from a total of 468 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
N/A |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Halcinonide topical prices |
View all Triamcinolone topical prices |
View all Dupixent prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Halog | Aricin, Aristocort A, Aristocort R, Cinalog, Cinolar, Delta-Tritex, DermacinRx Silazone, DermacinRx Trizapak, Dermasorb TA, Juulissa Pharmapak, Kenalog, Kourzeq, Oralone, SilaLite Pak, Treziopak, Trianex, Triasil, Triderm, Tritocin View more |
N/A |
||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 47 drugs are known to interact with Halcinonide topical:
|
A total of 48 drugs are known to interact with Triamcinolone topical:
|
A total of 88 drugs are known to interact with Dupixent:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
November 27, 1974 |
October 23, 1958 |
March 28, 2017 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.